Safi-Eddine, Z., Omary, S. and El Quars, F. (2024) Contribution to the Assessment of Nasal Dimensions in Facial Profile among a Moroccan Population: Cross-Sectional Descriptive Study. Open Access ...

You might have the same narrow nose as your mom, but new research has discovered that there's more to nose shape than genetics. Do you blame (or thank, depending on how you feel about it ...

No, we're not just talking about washing your hands. Prevent illnesses this fall and winter by making this a habit.

Nasal congestion could be a sign of sinusitis, which may lead to ear infections or even blindness. Japan's top nasal surgery hospital uses advanced equipment to perform sinus surgeries safely. If ...

Some essential oils may clear up nasal passages and relieve sinus pressure and other congestion symptoms. Sinus congestion is uncomfortable to say the least. It may make it difficult for you to ...

The makers of a nasal spray launched last year by start-up Akita Biosciences have pulled back the curtain on how their product works (Adv. Mater. 2024, DOI: 10.1002/adma.202406348). The company ...

Share on Pinterest Is FluMist, the at-home nasal vaccine that was recently approved by the FDA, as effective at preventing illness as traditional flu shots? Michael Buckner/Getty Images for ...

Support us to deliver journalism without an agenda. The Food and Drug Administration (FDA) has approved the first nasal spray flu vaccine which can be administered by the patient or a caregiver.

What is nasal triamcinolone used for? Nasal triamcinolone is commonly used to treat hay fever and allergy symptoms such as sneezing and runny, stuffy, or itchy nose. Nasal triamcinolone may ...

SoundHealth's technology can detect the data related to the quality of air, a person's nasal anatomy and also studies the ...

The Food and Drug Administration on Friday approved the first at-home flu vaccine, a nasal spray that consumers with a prescription will be able to order online starting next year. Health experts ...

GSK plc has announced positive results from its Phase III ANCHOR trials for depemokimab, a biologic treatment for chronic ...